First OSD Facility Commences Operations
(AF)

Hormonal Production Facility commenced

Sterile FDF Facility Commenced
(IM)

Second OSD Facility Commenced
(AG)

WHO Geneva Pre Qualification / INVIMA approval
(AF)

UKMHRA/ANVISA/PICS/ EUGMP/TGA/Health Canada Approvals New R&D Facility Commenced - New R&D Centre at Bengaluru commenced operations

USFDA Approval with ZERO 483
(IM)

ANDA Approvals: 25
Filings: 5

USFDA/EUGMP Approval Renewed

ANDA Approvals: 15
Filings: 15


USFDA Approval
(AG)

Sterile Capacity Expansion
Investment: USD 100 million
General/Oncology Liquid and Lyophlized Injectables | Ophthalmics | PFS & Cartridges (IM)
ANDA Approvals: 38; Filings: 19 (IM/AG)
Health Canada Approval Renewed (AG)
EU GMP Approval Renewed